GEORGE B ABERCROMBIE
CIK 1485939 · CHIEF EXECUTIVE OFFICER · last filed 2024-06-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.99M
Companies
7
Total Filings
47
Lifetime Open-Market Net
-$2.07M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCRX | Director | 36,431 | $8.70 | $316.9K | -$1.64M | 23 | 2024-06-14 |
| Fresh Tracks Therapeutics, Inc. (BBI) Delisted | CHIEF EXECUTIVE OFFICER | 19,312 | $2.35 | $45.4K | $0 | 1 | 2020-02-19 |
| INVA | Sr. VP & Chief Comm. Officer | 293,479 | $22.74 | $6.67M | -$429.3K | 14 | 2018-08-22 |
| Innoviva, Inc. (THRX) Delisted | Sr. VP, Corp. Partnerships | 81,429 | $4.06 | $330.6K | $0 | 1 | 2015-01-09 |
| Ocera Therapeutics, Inc. (TZYM) Delisted | Director | — | — | — | $0 | 3 | 2012-08-09 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | Director | 0 | — | — | $0 | 4 | 2011-05-16 |
| Alaunos Therapeutics, Inc. (ZIOP) Delisted | Director | 25,000 | $0.87 | $21.6K | $0 | 1 | 2010-04-06 |
Recent Filings · Page 3 of 5
47 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-11-22 | INVA | Mixed | −8,573 | -$113.4K | EDGAR |
| 2017-08-22 | INVA | Tax (F) | −2,886 | -$35.4K | EDGAR |
| 2017-05-25 | BCRX | Grant (A) | — | $0 | EDGAR |
| 2017-05-23 | INVA | Tax (F) | −2,228 | -$26.4K | EDGAR |
| 2017-02-22 | INVA | Tax (F) | −5,355 | -$64.5K | EDGAR |
| 2017-01-19 | INVA | Grant (A) | +106,718 | $0 | EDGAR |
| 2016-11-22 | INVA | Tax (F) | −1,273 | -$13.9K | EDGAR |
| 2016-08-23 | INVA | Tax (F) | −1,939 | -$22.9K | EDGAR |
| 2016-05-25 | BCRX | Grant (A) | — | $0 | EDGAR |
| 2016-05-20 | INVA | Tax (F) | −1,276 | -$14.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.